Anika Therapeutics, Inc. Operating Lease Right-of-Use Assets
Anika Therapeutics, Inc. (ANIK) had Operating Lease Right-of-Use Assets of $24.95 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-07-29
- 2026-06-30: Operating Lease, Right-of-Use Asset $24.95M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $25.43M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $25.94M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $24.23M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $24.95M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $25.43M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $25.94M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $24.23M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $24.72M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $25.18M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $25.68M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $27.21M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $27.77M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $28.18M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $27.55M 10-K · filed 2025-03-17 | $28.77M 10-K · filed 2024-03-15 |
| 2023-09-30 | $29.05M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $29.63M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $30.18M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $30.70M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $30.99M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $31.61M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $20.52M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $20.96M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $21.40M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $21.85M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $22.32M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $22.62M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $22.90M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $23.20M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $23.53M 10-Q · filed 2020-05-22 | |
| 2019-12-31 | $22.86M 10-K/A · filed 2021-04-26 | |
| 2019-09-30 | $23.08M 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $23.50M 10-Q · filed 2019-07-26 | |
| 2019-03-31 | $23.75M 10-Q · filed 2019-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |